IMMATICS N.V's ticker is IMTX and the CUSIP is N44445109. A total of 78 filers reported holding IMMATICS N.V in Q4 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,300,760 | -44.7% | 198,000 | -50.0% | 0.48% | -25.2% |
| Q1 2024 | $4,161,960 | -0.2% | 396,000 | 0.0% | 0.64% | -0.8% |
| Q4 2023 | $4,169,880 | -9.1% | 396,000 | 0.0% | 0.65% | -53.8% |
| Q3 2023 | $4,585,680 | +0.3% | 396,000 | 0.0% | 1.40% | +75.1% |
| Q2 2023 | $4,569,840 | +33.8% | 396,000 | -20.0% | 0.80% | +13.6% |
| Q1 2023 | $3,415,500 | -20.8% | 495,000 | 0.0% | 0.71% | -23.9% |
| Q4 2022 | $4,311,450 | – | 495,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 697,431 | $8,048 | 3.11% |
| Nantahala Capital Management | 2,284,895 | $26,367,688 | 2.55% |
| Sofinnova Investments, Inc. | 3,041,487 | $35,098,760 | 2.30% |
| Paradigm Biocapital Advisors LP | 1,984,813 | $22,904,742 | 1.77% |
| Affinity Asset Advisors, LLC | 300,000 | $3,462,000 | 1.21% |
| Perceptive Advisors | 3,491,500 | $40,291,910 | 1.17% |
| 683 Capital Management, LLC | 1,350,000 | $15,579,000 | 1.12% |
| SPHERA FUNDS MANAGEMENT LTD. | 617,173 | $7,122,176 | 1.11% |
| Samsara BioCapital, LLC | 396,000 | $4,569,840 | 0.80% |
| Logos Global Management LP | 500,000 | $5,770,000 | 0.78% |